BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3918513)

  • 1. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
    Dewis P; Prasad BK; Anderson DC; Willets S
    Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
    Mautalen CA; Gonzalez D; Ghiringhelli G
    Bone; 1985; 6(6):429-32. PubMed ID: 4096879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G; Delwaide P; Bijvoet OL; Franchimont P
    Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650
    [No Abstract]   [Full Text] [Related]  

  • 9. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
    Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
    Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of remission of Paget's disease of bone.
    Patel S; Stone MD; Coupland C; Hosking DJ
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC; Khairi MR; Meunier PJ
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K; Merry P; Scott DG
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
    Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
    Bone; 1985; 6(2):69-72. PubMed ID: 2409999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
    Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
    Bijvoet OL; Frijlink WB; Jie K; van der Linden H; Meijer CJ; Mulder H; van Paassen HC; Reitsma PH; te Velde J; de Vries E; van der Wey JP
    Arthritis Rheum; 1980 Oct; 23(10):1193-204. PubMed ID: 6448605
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphosphonate therapy of paget's disease of bone.
    Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
    J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.